Extra Super VegaForce 10 Tablets

Expert advice for Extra Super VegaForce

• An orthostatic test should be performed before starting therapy with Sildenafil Dapoxetine combination tablet like Super VegaForce. In case of a history of documented or suspected orthostatic reaction, treatment with Super VegaForce must be avoided.
• Dapoxetine Sildenafil tablets should not be used in patients with a history of mania/hypomania or bipolar disorder and Super VegaForce therapy should be stopped in any patient who develops symptoms of these disorders.
• Super VegaForce should be discontinued in any patient who develops seizures and avoided in patients with unstable epilepsy.
• Men with underlying signs and symptoms of depression should be evaluated before starting treatment with Super VegaForce to rule out undiagnosed depressive disorders. There have been reports of bleeding abnormalities with SSRIs like Dapoxetine Hydrochloride.
• Caution is advised in patients taking Super VegaForce, particularly in concomitant use with medicinal products known to affect platelet function
• Super VegaForce is not recommended for use in patients with severe renal impairment and caution is advised in patients with mild or moderate renal impairment.
• As with other SSRIs, Dapoxetine Hydrochloride has been associated with mild ocular effects such as mydriasis. Therefore Super VegaForce should be used with caution in patients with raised intraocular pressure or those at risk of angle-closure glaucoma.
• Patients should not use Dapoxetine Sildenafil tablets (Super VegaForce) if sexual activity is not advisable due to cardiovascular status
• Patients should seek emergency treatment if an erection lasts for more than four hours. Use Sildenafil or Super VegaForce tablets with caution in patients predisposed to priapism.
• Patients should stop Super VegaForce and seek medical care if a sudden loss of vision occurs in one or both eyes, which could be a sign of non arteritic anterior ischemic optic neuropathy (NAION). Super VegaForce should be used with caution, and only when the anticipated benefits outweigh the risks, in patients with a history of NAION. Patients with a “crowded” optic disc may also be at an increased risk of NAION.
  Patients should stop Super VegaForce tablets and seek prompt medical attention in the event of sudden decrease or loss of hearing.
• Caution is advised when Super VegaForce (Sildenafil Dapoxetine Tablets) is co-administered with alpha-blockers or anti-hypertensives. Concomitant use may lead to hypotension.
• Decreased blood pressure, syncope, and prolonged erection may occur at higher sildenafil exposures. In patients taking strong CYP inhibitors, such as ritonavir, sildenafil exposure is increased.